TNF Drives Monocyte Dysfunction with Age and Results in Impaired Anti-pneumococcal Immunity

F Geissmann, 2003, Blood monocytes consist of two principal subsets with distinct migratory properties, Immunity, 19, 71, 10.1016/S1074-7613(03)00174-2

S Gordon, 2005, Monocyte and macrophage heterogeneity, Nat Rev Immunol, 5, 953, 10.1038/nri1733

J Cros, 2010, Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors, Immunity, 33, 375, 10.1016/j.immuni.2010.08.012

R Barbalat, 2009, Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands, Nat Immunol, 10, 1200, 10.1038/ni.1792

IR Dunay, 2008, Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii, Immunity, 29, 306, 10.1016/j.immuni.2008.05.019

NV Serbina, 2008, Monocyte-mediated defense against microbial pathogens, Annu Rev Immunol, 26, 421, 10.1146/annurev.immunol.26.021607.090326

YG Kim, 2011, The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes, Immunity, 34, 769, 10.1016/j.immuni.2011.04.013

S Seidler, 2010, Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults, BMC Immunol, 11, 30, 10.1186/1471-2172-11-30

L Alvarez-Rodriguez, 2012, Aging is associated with circulating cytokine dysregulation, Cell Immunol, 273, 124, 10.1016/j.cellimm.2012.01.001

A Merino, 2011, Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity, J Immunol, 186, 1809, 10.4049/jimmunol.1001866

E Lutgens, 2010, Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile, J Exp Med, 207, 391, 10.1084/jem.20091293

F Tacke, 2007, Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques, J Clin Invest, 117, 185, 10.1172/JCI28549

IL King, 2009, Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease, Blood, 113, 3190, 10.1182/blood-2008-07-168575

HG Martinez, 2011, Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome, Diabetologia, 54, 2660, 10.1007/s00125-011-2248-8

A Rivollier, 2012, Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon, J Exp Med, 209, 139, 10.1084/jem.20101387

G Ren, 2012, CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFalpha, Cell Stem Cell, 11, 812, 10.1016/j.stem.2012.08.013

BT van den Brand, 2013, Intravenous delivery of HIV-based lentiviral vectors preferentially transduces F4/80+ and Ly-6C+ cells in spleen, important target cells in autoimmune arthritis, PLoS One, 8, e55356, 10.1371/journal.pone.0055356

FK Swirski, 2007, Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata, J Clin Invest, 117, 195, 10.1172/JCI29950

F Leuschner, 2011, Therapeutic siRNA silencing in inflammatory monocytes in mice, Nat Biotechnol, 29, 1005, 10.1038/nbt.1989

FK Swirski, 2006, Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease, Proc Natl Acad Sci U S A, 103, 10340, 10.1073/pnas.0604260103

C Franceschi, 2007, Inflammaging as a major characteristic of old people: can it be prevented or cured?, Nutr Rev, 65, S173, 10.1301/nr.2007.dec.S173-S176

C Franceschi, 2007, Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans, Mech Ageing Dev, 128, 92, 10.1016/j.mad.2006.11.016

R Medzhitov, 2008, Origin and physiological roles of inflammation, Nature, 454, 428, 10.1038/nature07201

ME Starr, 2009, Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6, J Gerontol A Biol Sci Med Sci, 64, 723, 10.1093/gerona/glp046

M Bonafe, 2012, Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people, Bioessays, 34, 40, 10.1002/bies.201100104

MN Bouchlaka, 2013, Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy, J Exp Med, 210, 2223, 10.1084/jem.20131219

OV Forlenza, 2009, Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment, Dement Geriatr Cogn Disord, 28, 507, 10.1159/000255051

W Whiteley, 2009, Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6, PLoS Med, 6, e1000145, 10.1371/journal.pmed.1000145

M Cesari, 2003, Inflammatory markers and onset of cardiovascular events: results from the Health ABC study, Circulation, 108, 2317, 10.1161/01.CIR.0000097109.90783.FC

H Li, 2011, Frailty, inflammation, and immunity, Aging Dis, 2, 466

S Giovannini, 2011, Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals, J Am Geriatr Soc, 59, 1679, 10.1111/j.1532-5415.2011.03570.x

R Varadhan, 2014, Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults, J Gerontol A Biol Sci Med Sci, 69, 165, 10.1093/gerona/glt023

K Tuomisto, 2006, C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study, Thromb Haemost, 95, 511, 10.1160/TH05-08-0571

TB Harris, 1999, Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly, Am J Med, 106, 506, 10.1016/S0002-9343(99)00066-2

KC Torres, 2014, Increased frequency of cluster of differentiation 14 (CD14+) monocytes expressing interleukin 1 beta (IL-1beta) in Alzheimer's disease patients and intermediate levels in late-onset depression patients, Int J Geriatr Psychiatry, 29, 137, 10.1002/gps.3973

T Qu, 2009, Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14(+) monocytes in frail older adults, Mech Ageing Dev, 130, 161, 10.1016/j.mad.2008.10.005

SX Leng, 2004, Decreased cell proliferation and altered cytokine production in frail older adults, Aging Clin Exp Res, 16, 249, 10.1007/BF03327392

KS Rogacev, 2012, CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography, J Am Coll Cardiol, 60, 1512, 10.1016/j.jacc.2012.07.019

KE Berg, 2012, Elevated CD14++CD16- monocytes predict cardiovascular events, Circ Cardiovasc Genet, 5, 122, 10.1161/CIRCGENETICS.111.960385

GH Heine, 2008, CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients, Kidney Int, 73, 622, 10.1038/sj.ki.5002744

M Kaito, 2013, Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients, PLoS One, 8, e69409, 10.1371/journal.pone.0069409

P Shivshankar, 2012, Modulation of bacterial pathogenesis by oppressive aging factors: insights into host-pneumococcal interaction strategies, ISRN Inflamm, 2012, 267101, 10.5402/2012/267101

G Antunes, 2002, Systemic cytokine levels in community-acquired pneumonia and their association with disease severity, Eur Respir J, 20, 990, 10.1183/09031936.02.00295102

P Glynn, 1999, Circulating interleukin 6 and interleukin 10 in community acquired pneumonia, Thorax, 54, 51, 10.1136/thx.54.1.51

S Yende, 2006, Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects, Thorax, 61, 10, 10.1136/thx.2004.034181

E Hinojosa, 2009, Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia, J Infect Dis, 200, 546, 10.1086/600870

H Geiger, 2013, The ageing haematopoietic stem cell compartment, Nat Rev Immunol, 13, 376, 10.1038/nri3433

RH Cho, 2008, A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells, Blood, 111, 5553, 10.1182/blood-2007-11-123547

CL Tsou, 2007, Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites, J Clin Invest, 117, 902, 10.1172/JCI29919

DR Getts, 2014, Therapeutic inflammatory monocyte modulation using immune-modifying microparticles, Sci Transl Med, 6, 219ra217, 10.1126/scitranslmed.3007563

A Schlitt, 2004, CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels, Thromb Haemost, 92, 419, 10.1160/TH04-02-0095

HM Mehta, 2014, Systems approach to phagocyte production and activation: neutrophils and monocytes, Adv Exp Med Biol, 844, 99, 10.1007/978-1-4939-2095-2_6

Z Zhang, 2009, Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice, J Clin Invest, 119, 1899

KM Davis, 2011, Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice, J Clin Invest, 121, 3666, 10.1172/JCI57761

S Yende, 2005, Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia, Am J Respir Crit Care Med, 172, 1440, 10.1164/rccm.200506-888OC

MS Paats, 2013, Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia, Eur Respir J, 41, 1378, 10.1183/09031936.00060112

S Yende, 2008, Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis, Am J Respir Crit Care Med, 177, 1242, 10.1164/rccm.200712-1777OC

VF Corrales-Medina, 2015, Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease, JAMA, 313, 264, 10.1001/jama.2014.18229

FA Shah, 2013, Bidirectional relationship between cognitive function and pneumonia, Am J Respir Crit Care Med, 188, 586, 10.1164/rccm.201212-2154OC

S Yende, 2010, The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies, Thorax, 65, 870, 10.1136/thx.2010.136317

C Franceschi, 2000, Inflamm-aging. An evolutionary perspective on immunosenescence, Ann N Y Acad Sci, 908, 244, 10.1111/j.1749-6632.2000.tb06651.x

CP Verschoor, 2014, Alterations to the frequency and function of peripheral blood monocytes and associations with chronic disease in the advanced-age, frail elderly, PLoS One, 9, e104522, 10.1371/journal.pone.0104522

L Chara, 2012, Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis, Arthritis Res Ther, 14, R175, 10.1186/ar3928

L Xia, 2011, Blockage of TNF-alpha by infliximab reduces CCL2 and CCR2 levels in patients with rheumatoid arthritis, J Investig Med, 59, 961, 10.2310/JIM.0b013e31821c0242

AC Kirby, 2005, The role played by tumor necrosis factor during localized and systemic infection with Streptococcus pneumoniae, J Infect Dis, 191, 1538, 10.1086/429296

F Wolfe, 2006, Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy, Arthritis Rheum, 54, 628, 10.1002/art.21568

GR Burmester, 2009, Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases, Ann Rheum Dis, 68, 1863, 10.1136/ard.2008.102103

GR Burmester, 2013, Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease, Ann Rheum Dis, 72, 517, 10.1136/annrheumdis-2011-201244

OS Sogaard, 2011, The clinical use of adjuvants in pneumococcal vaccination: current status and future perspectives, Hum Vaccin, 7, 276, 10.4161/hv.7.2.13919

AC Cheng, 2007, Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults, Cochrane Database Syst Rev, CD004400

RA Siemieniuk, 2015, Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis, Ann Intern Med

HH Remmelts, 2012, Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia, Clin Vaccine Immunol, 19, 1532, 10.1128/CVI.00423-12

HH Remmelts, 2012, Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia, J Infect, 65, 25, 10.1016/j.jinf.2012.03.008

SC Meijvis, 2011, Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial, Lancet, 377, 2023, 10.1016/S0140-6736(11)60607-7

A Puchta, 2014, Characterization of inflammatory responses during intranasal colonization with Streptococcus pneumoniae, J Vis Exp, e50490

A Zganiacz, 2004, TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection, J Clin Invest, 113, 401, 10.1172/JCI18991